ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.
Company Information
About this company
Key people
R. John Fletcher
Independent Chairman of the Board
Joseph Michael Burnett
President, Chief Executive Officer, Director
Danilo D' Alessandro
Chief Financial Officer
Jeremy L. Stigall
Chief Business Officer
Lynnette C. Fallon
Independent Director
B. Kristine Olson Johnson
Independent Director
Matthew B. Klein
Independent Director
Linda M. Liau
Independent Director
Click to see more
Key facts
- Shares in issue29.99m
- EPICCLPT
- ISINUS18507C1036
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$343.08m
- Employees172
- ExchangeNASDAQ
- IndexTR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.